跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
查看斯高帕斯 (Scopus) 概要
張 榮善
教授
,
醫學科學研究所
合聘副教授
,
國際醫學研究碩士學位學程
合聘副教授
,
國際醫學研究博士學位學程
合聘副教授
,
細胞治療與再生醫學國際博士學位學程
https://orcid.org/0000-0002-9537-064X
電子郵件
js.chang
tmu.edu
tw
h-index
2109
引文
24
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2000 …
2026
每年研究成果
概覽
指紋
網路
專案
(16)
研究成果
(59)
資料集
(23)
類似的個人檔案
(6)
指紋
查看啟用 Jungshan Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Immunology and Microbiology
Cytotoxic T-Cell
100%
Lung
83%
Neutrophil
78%
Interferon Type I
66%
Leukocyte
62%
Programmed Death-Ligand 1
61%
E-Selectin
49%
Sickle Cell
48%
SAD Mouse
45%
T Cell
41%
Tumor Cell
41%
CXCL10
40%
Erythrocyte
39%
T Cell Activation
37%
Radioresistance
36%
Matrix-Assisted Laser Desorption-Ionization
36%
Squamous Cell
36%
Epidermal Growth Factor
36%
STAT3
35%
CD8
35%
In Vitro
35%
Selectin
31%
STAT1
29%
Cancer Cell
27%
Granzyme B
24%
Blood Flow
24%
Tumor Necrosis Factor
24%
Interleukin 6
23%
Cell Activity
22%
Cell Migration
21%
Inflammation
20%
Venule
20%
Time-of-Flight Mass Spectrometry
19%
Colon
19%
Cancer Tissue
18%
Cytotoxic T Cell
18%
Imaging Mass Spectrometry
18%
Intravenous Immunoglobulin
18%
Intercellular Adhesion Molecule 1
18%
Single-Chain Variable Fragment
18%
Sorafenib
18%
Alpha Chain
18%
Tumor Hypoxia
18%
Histamine
18%
Peptides
18%
Neurofilament
18%
Streptococcus pneumonia
18%
Susceptibility
18%
Cerebrospinal Fluid
18%
Phosphoprotein
18%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
93%
Colorectal Carcinoma
90%
Neoplasm
87%
Epidermal Growth Factor Receptor
54%
Triple Negative Breast Cancer
54%
Biological Marker
47%
Hypoxia
45%
Cytotoxicity
39%
Tumor Growth
38%
Lung Cancer
38%
Nanoparticle
38%
Gold Nanoparticle
36%
Tumor Microenvironment
36%
Nicotinic Receptor
36%
Nanocarrier
36%
Micelle
36%
Hydrogen Peroxide
33%
Reactive Oxygen Metabolite
30%
Liver Fibrosis
30%
Sepantronium Bromide
24%
Breast Cancer
22%
Abdominal Cancer
22%
Indium 111
22%
Chemotherapy Regimens
21%
Matrix-Assisted Laser Desorption/Ionization
21%
Afatinib
20%
Peroxide
19%
Glucose Regulated Protein 78
18%
Tumor Necrosis Factor
18%
Inflammation
18%
Drug Delivery System
18%
Interleukin Enhancer Binding Factor 3
18%
Penicillamine
18%
Heme Oxygenase 1
18%
Tirapazamine
18%
Vasculotropin
18%
AM251
18%
Cannabinoid 1 Receptor Antagonist
18%
Cannabinoid 1 Receptor
18%
Alcoholic Fatty Liver
18%
Polypeptide
18%
Protoporphyrin Zinc
18%
Naja Atra
18%
Quercetin
18%
Nanobody
18%
Lethality
18%
Alpaca
18%
Aptamer
18%
Antitumor Activity
18%
Phosphoprotein
18%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
90%
STAT3
40%
Cancer Cell
40%
Colon
30%
Nicotinic Acetylcholine Receptor
22%
Epidermal Growth Factor
22%
Tumor Progression
21%
Stem Cell
21%
Peptide
21%
Molecular Mechanism
21%
PD-L1
21%
Messenger RNA
20%
Survival Rate
20%
Cyclic Adenosine Monophosphate
20%
Matrix-Assisted Laser Desorption/Ionization
19%
Time-of-Flight Mass Spectrometry
19%
Rat
19%
Carcinogenesis
19%
Expression Level
18%
Angiogenesis
18%
STAT1
18%
CHRNA5
18%
Autophosphorylation
18%
Neutrophil Elastase
18%
MALDI Imaging
18%
Imaging Mass Spectrometry
18%
Lipolysis
18%
Transmission Electron Microscopy
18%
SETDB1
18%
Lipid Droplet
18%
Receptor Tyrosine Kinase Inhibitors
18%
Zinc Protoporphyrin
18%
WNK1
18%
Histone Methyltransferase
18%
Glucose-Regulated Protein
18%
Heme Oxygenase
18%
Tumor Hypoxia
18%
Vascular Endothelial Growth Factor
18%
Single-Chain Variable Fragment
18%
Phosphoprotein
18%
Quercetin
18%
Single-Nucleotide Polymorphism
18%
Mitochondrial Membrane Potential
18%
Cisplatin
18%
Dopamine
18%
Aqueous Solution
18%
Nicotinic Receptor
18%
Perilipin
18%
Photobiomodulation
18%
Cannabinoid
18%
